Intellicheck Announces Record Third Quarter Fiscal 2021 Financial Results
Intellicheck, Inc. (Nasdaq: IDN) reported a 79% increase in revenue for Q3 2021, reaching $4.83 million, up from $2.7 million in Q3 2020. SaaS revenue surged 32% to $3.25 million. However, the company faced a net loss of $952,000 or $0.05 per diluted share. Gross profit margin also declined to 68.7% from 89.1% year-over-year, primarily due to lower-margin hardware sales. Adjusted EBITDA was a loss of $271,000, contrasting with a gain of $169,000 in the prior year. As of September 30, cash totaled $13.3 million.
- Record revenue growth of 79% to $4.83 million in Q3 2021.
- SaaS revenue increased by 32% to $3.25 million.
- Cash position strengthened with $13.3 million available.
- Net loss of $952,000 for Q3 2021 compared to a profit of $32,000 in Q3 2020.
- Gross profit margin declined to 68.7% from 89.1% year-over-year.
- Adjusted EBITDA showed a loss of $271,000, down from a gain of $169,000.
Revenue Climbed
SaaS Revenue Grew
CEO
Gross profit as a percentage of revenues was
Net loss for the three months ended
Adjusted EBITDA (earnings before interest and other income (expense), income taxes, depreciation, amortization, stock-based compensation expense and certain non-recurring charges) was a loss of (
Cash at
The financial results reported today do not take into account any adjustments that may be required in connection with the completion of the Company’s review process and should be considered preliminary until the Company files its Form 10-Q for the fiscal period ended
Conference Call Information
The Company will hold an earnings conference call on
A replay of the conference call will be available shortly after completion of the live event. To listen to the replay, please dial 877-660-6853 and use conference identification number 13724569. For callers outside the
|
||||||
BALANCE SHEETS |
||||||
ASSETS |
||||||
|
|
|||||
2021 |
2020 |
|||||
(Unaudited) |
||||||
CURRENT ASSETS: |
||||||
Cash |
$ |
13,266,031 |
$ |
13,121,392 |
||
Accounts receivable, net of allowance of |
2,777,222 |
2,119,861 |
||||
Other current assets |
869,583 |
340,718 |
||||
Total current assets |
16,912,836 |
15,581,971 |
||||
|
|
|||||
PROPERTY AND EQUIPMENT, net |
430,341 |
138,870 |
||||
|
8,101,661 |
8,101,661 |
||||
INTANGIBLE ASSETS, net |
403,856 |
482,591 |
||||
OPERATING LEASE RIGHT-OF-USE ASSET |
|
|
- |
|
|
31,131 |
OTHER ASSETS |
8,500 |
4,250 |
||||
Total assets |
$ |
25,857,194 |
$ |
24,340,474 |
||
|
|
|||||
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||
|
|
|||||
CURRENT LIABILITIES: |
|
|
||||
Accounts payable |
$ |
231,780 |
$ |
46,171 |
||
Accrued expenses |
2,445,534 |
1,638,798 |
||||
Operating lease liability, current portion |
|
|
- |
|
|
32,620 |
Deferred revenue, current portion |
1,372,311 |
402,782 |
||||
Total current liabilities |
4,049,625 |
2,120,371 |
||||
|
|
|||||
OTHER LIABILITIES: |
|
|
||||
Deferred revenue, long-term portion |
9,737 |
8,662 |
||||
Total liabilities |
4,059,362 |
2,129,033 |
||||
|
|
|||||
COMMITMENTS AND CONTINGENCIES |
|
|
||||
|
|
|||||
STOCKHOLDERS’ EQUITY: |
|
|
||||
Common stock - |
18,736 |
18,410 |
||||
Additional paid-in capital |
140,905,895 |
138,569,746 |
||||
Accumulated deficit |
(119,126,799) |
(116,376,715) |
||||
Total stockholders' equity |
21,797,832 |
22,211,441 |
||||
|
|
|||||
Total liabilities and stockholders' equity |
$ |
25,857,194 |
$ |
24,340,474 |
|
||||||||||||
|
||||||||||||
STATEMENTS OF OPERATIONS |
||||||||||||
(Unaudited) |
||||||||||||
|
Three months ended |
Nine months ended |
||||||||||
|
2021 |
2020 |
2021 |
2020 |
||||||||
|
|
|
|
|
|
|
|
|
||||
REVENUES |
$ |
4,831,229 |
$ |
2,698,975 |
$ |
12,490,911 |
$ |
7,656,442 |
||||
COST OF REVENUES |
|
(1,510,590) |
|
(293,699) |
|
(3,199,834) |
|
(1,196,528) |
||||
Gross profit |
|
3,320,639 |
|
2,405,276 |
|
9,291,077 |
|
6,459,914 |
||||
|
|
|
|
|
|
|
|
|||||
OPERATING EXPENSES |
|
|
|
|
|
|
|
|
||||
Selling, general and administrative |
|
2,856,794 |
|
1,472,094 |
|
7,951,970 |
|
4,341,985 |
||||
Research and development |
|
1,415,666 |
|
907,763 |
|
4,104,531 |
|
2,837,374 |
||||
Total operating expenses |
|
4,272,460 |
|
2,379,857 |
|
12,056,501 |
|
7,179,359 |
||||
|
|
|
|
|
|
|
|
|||||
(Loss) Income from operations |
|
(951,821) |
|
25,419 |
|
(2,765,424) |
|
(719,445) |
||||
|
|
|
|
|
|
|
|
|||||
OTHER INCOME (EXPENSE) |
|
|
|
|
|
|
|
|
||||
Gain on forgiveness of unsecured promissory note |
|
- |
|
- |
|
10,000 |
|
- |
||||
Interest and other income (expense), net |
|
(412) |
|
6,993 |
|
5,340 |
|
18,186 |
||||
Total other income (expense) |
|
(412) |
|
6,993 |
|
15,340 |
|
18,186 |
||||
|
|
|
|
|
|
|
|
|||||
Net (loss) income |
$ |
(952,233) |
$ |
32,412 |
$ |
(2,750,084) |
$ |
(701,259) |
||||
|
|
|
|
|
|
|
|
|||||
PER SHARE INFORMATION |
|
|
|
|
|
|
|
|
||||
(Loss) Income per common share - |
|
|
|
|
|
|
|
|
||||
Basic |
$ |
(0.05) |
$ |
0.00 |
$ |
(0.15) |
$ |
(0.04) |
||||
Diluted |
$ |
(0.05) |
$ |
0.00 |
$ |
(0.15) |
$ |
(0.04) |
||||
|
|
|
|
|
|
|
|
|
||||
Weighted average common shares used in computing per share amounts |
||||||||||||
Basic |
|
18,735,097 |
|
18,336,107 |
|
18,653,823 |
|
16,960,770 |
||||
Diluted |
|
18,735,097 |
|
18,764,994 |
|
18,653,823 |
|
16,960,770 |
||||
|
||||||||||||||
|
||||||||||||||
STATEMENTS OF STOCKHOLDERS’ EQUITY |
||||||||||||||
(Unaudited) |
||||||||||||||
|
Three months ended |
|||||||||||||
|
|
|
|
|
Additional |
|
|
|
|
Total |
||||
Common Stock |
|
Paid-in |
|
Accumulated |
|
Stockholders’ |
||||||||
Shares |
|
Amount |
|
Capital |
|
Deficit |
|
Equity |
||||||
BALANCE, |
18,727,552 |
$ |
18,728 |
$ |
140,267,314 |
$ |
(118,174,566) |
$ |
22,111,476 |
|||||
|
|
|
|
|||||||||||
Stock-based compensation expense |
- |
|
- |
|
638,589 |
|
- |
|
638,589 |
|||||
Issuance of shares for restricted stock grants |
8,363 |
|
8 |
|
(8) |
|
- |
|
- |
|||||
Net loss |
- |
|
- |
|
- |
|
(952,233) |
|
(952,233) |
|||||
BALANCE, |
18,735,915 |
$ |
18,736 |
$ |
140,905,895 |
$ |
(119,126,799) |
$ |
21,797,832 |
|||||
|
|
|
|
|
|
|
|
|
|
|||||
|
Three months ended |
|||||||||||||
|
|
|
|
|
Additional |
|
|
|
|
Total |
||||
Common Stock |
|
Paid-in |
|
Accumulated |
|
Stockholders’ |
||||||||
Shares |
|
Amount |
|
Capital |
|
Deficit |
|
Equity |
||||||
BALANCE, |
18,028,282 |
$ |
18,028 |
$ |
139,715,197 |
$ |
(117,668,783) |
$ |
22,064,442 |
|||||
|
|
|
||||||||||||
Stock-based compensation expense |
- |
|
- |
|
97,157 |
|
- |
|
97,157 |
|||||
Exercise of stock options, net of cashless exercise of 82,161 shares |
527,214 |
|
527 |
|
28,823 |
|
- |
|
29,350 |
|||||
Exercise of warrants |
750 |
|
1 |
|
1,649 |
|
- |
|
1,650 |
|||||
Issuance of shares for restricted stock grants |
7,284 |
|
7 |
|
(7) |
|
- |
|
- |
|||||
Settlement of executive bonuses with issuance of restricted stock units |
5,531 |
|
6 |
|
31,245 |
|
- |
|
31,251 |
|||||
Shares forfeited in exchange for withholding taxes |
(178,832) |
|
(179) |
|
(1,462,415) |
|
- |
|
(1,462,594) |
|||||
Net income |
- |
|
- |
|
- |
|
32,412 |
|
32,412 |
|||||
BALANCE, |
18,390,229 |
$ |
18,390 |
$ |
138,411,649 |
$ |
(117,636,371) |
$ |
20,793,668 |
|
||||||||||||||
|
||||||||||||||
STATEMENTS OF STOCKHOLDERS’ EQUITY |
||||||||||||||
(Unaudited) |
||||||||||||||
|
Nine months ended |
|||||||||||||
|
|
|
Additional |
|
|
Total |
||||||||
Common Stock |
Paid-in |
Accumulated |
Stockholders’ |
|||||||||||
Shares |
Amount |
Capital |
Deficit |
Equity |
||||||||||
BALANCE, |
18,410,458 |
$ |
18,410 |
$ |
138,569,746 |
$ |
(116,376,715) |
$ |
22,211,441 |
|||||
|
|
|
|
|||||||||||
Stock-based compensation expense |
- |
|
- |
|
2,270,205 |
|
- |
|
2,270,205 |
|||||
Exercise of stock options, net of cashless exercise of 58,122 shares |
299,179 |
|
299 |
|
46,171 |
|
- |
|
46,470 |
|||||
Exercise of warrants |
9,000 |
|
9 |
|
19,791 |
|
- |
|
19,800 |
|||||
Issuance of shares for restricted stock grants |
17,278 |
|
18 |
|
(18) |
|
- |
|
- |
|||||
Net loss |
- |
|
- |
|
- |
|
(2,750,084) |
|
(2,750,084) |
|||||
BALANCE, |
18,735,915 |
$ |
18,736 |
$ |
140,905,895 |
$ |
(119,126,799) |
$ |
21,797,832 |
|||||
|
|
|
|
|
|
|
|
|
|
|||||
|
Nine months ended |
|||||||||||||
|
|
|
Additional |
|
|
Total |
||||||||
Common Stock |
Paid-in |
Accumulated |
Stockholders’ |
|||||||||||
Shares |
Amount |
Capital |
Deficit |
Equity |
||||||||||
BALANCE, |
16,041,650 |
$ |
16,042 |
$ |
128,668,583 |
$ |
(116,935,112) |
$ |
11,749,513 |
|||||
|
|
|||||||||||||
Stock-based compensation expense |
- |
|
- |
|
286,909 |
|
- |
|
286,909 |
|||||
Issuance of common stock, net of costs |
1,769,230 |
|
1,769 |
|
10,567,698 |
|
- |
|
10,569,467 |
|||||
Exercise of stock options, net of cashless exercise of 93,570 shares |
674,171 |
|
674 |
|
167,934 |
|
- |
|
168,608 |
|||||
Exercise of warrants |
50,750 |
|
51 |
|
111,599 |
|
- |
|
111,650 |
|||||
Issuance of shares for restricted stock grants |
20,279 |
|
20 |
|
(20) |
|
- |
|
- |
|||||
Settlement of executive bonuses with issuance of restricted stock units |
14,993 |
|
15 |
|
84,696 |
|
- |
|
84,711 |
|||||
Shares forfeited in exchange for withholding taxes |
(180,844) |
|
(181) |
|
(1,475,750) |
|
- |
|
(1,475,931) |
|||||
Net loss |
- |
|
- |
|
- |
|
(701,259) |
|
(701,259) |
|||||
BALANCE, |
18,390,229 |
$ |
18,390 |
$ |
138,411,649 |
$ |
(117,636,371) |
$ |
20,793,668 |
|||||
|
||||||
|
||||||
STATEMENTS OF CASH FLOWS |
||||||
(Unaudited) |
||||||
|
Nine months ended |
|||||
|
2021 |
2020 |
||||
|
|
|
|
|
||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
||
Net loss |
$ |
(2,750,084) |
$ |
(701,259) |
||
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: |
|
|
|
|
||
Depreciation and amortization |
|
126,226 |
|
127,143 |
||
Stock-based compensation expense |
|
2,270,205 |
|
286,909 |
||
Forgiveness of unsecured promissory note |
|
(10,000) |
|
- |
||
Changes in assets and liabilities: |
|
|
|
|
||
(Increase) in accounts receivable |
|
(657,361) |
|
(64,228) |
||
(Increase) in other current assets |
|
(528,865) |
|
(192,103) |
||
(Increase) in other assets |
|
(4,250) |
|
- |
||
Increase in accounts payable and accrued expenses |
|
990,856 |
|
361,395 |
||
Increase (decrease) in deferred revenue |
|
970,604 |
|
(128,779) |
||
Net cash provided by (used in) operating activities |
|
407,331 |
|
(310,922) |
||
|
|
|
|
|
||
|
|
|
|
|
||
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
||
Purchase of software license |
|
- |
|
(400,000) |
||
Capital expenditures |
|
(338,962) |
|
(36,520) |
||
Collection of note receivable |
|
- |
|
29,017 |
||
Net cash used in investing activities |
|
(338,962) |
|
(407,503) |
||
|
|
|
|
|
||
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
||
Return of repayment on unsecured promissory note |
|
10,000 |
|
- |
||
Net proceeds from issuance of common stock |
|
- |
|
10,569,467 |
||
Loan proceeds on unsecured promissory note |
|
- |
|
806,100 |
||
Net proceeds from issuance of common stock from exercise of stock options |
|
46,470 |
|
168,608 |
||
Proceeds from issuance of common stock from exercise of warrants |
|
19,800 |
|
111,650 |
||
Withholding taxes paid on exercise of stock options and vesting of restricted stock units |
|
- |
|
(1,475,931) |
||
Net cash provided by financing activities |
|
76,270 |
|
10,179,894 |
||
|
|
|
|
|
||
Net increase in cash |
|
144,639 |
|
9,461,469 |
||
|
|
|
|
|
||
CASH, beginning of period |
|
13,121,392 |
|
3,350,853 |
||
|
|
|
|
|
||
CASH, end of period |
$ |
13,266,031 |
$ |
12,812,322 |
||
|
|
|
|
|
||
Supplemental disclosure of noncash investing and financing activities: |
|
|
|
|
||
Settlement of executive bonuses with restricted stock units |
$ |
- |
$ |
84,710 |
||
|
|
|
|
|
Adjusted EBITDA
We use Adjusted EBITDA as a non-GAAP financial performance measurement. Adjusted EBITDA is calculated by adjusting net (loss) income for certain reductions such gains on debt forgiveness and interest and other income (expense) and certain addbacks such as income taxes, impairments of long-lived assets and goodwill, depreciation, amortization, and stock-based compensation expense. Adjusted EBITDA is provided to investors to supplement the results of operations reported in accordance with GAAP. Management believes that Adjusted EBITDA provides an additional tool for investors to use in comparing our financial results with other companies that also use Adjusted EBITDA in their communications to investors. By excluding non-cash charges such as impairments of long-lived assets and goodwill, amortization, depreciation, and stock-based compensation, as well as non-operating charges for interest and income taxes, investors can evaluate our operations and can compare the results on a more consistent basis to the results of other companies. In addition, Adjusted EBITDA is one of the primary measures management uses to monitor and evaluate financial and operating results.
We consider Adjusted EBITDA to be an important indicator of our operational strength and performance of our business and a useful measure of our historical operating trends. However, there are significant limitations to the use of Adjusted EBITDA since it excludes gains on debt forgiveness, interest and other income (expense), impairments of long-lived assets and goodwill, stock-based compensation expense, all of which impact our profitability, as well as depreciation and amortization related to the use of long-term assets which benefit multiple periods. We believe that these limitations are compensated by providing Adjusted EBITDA only with GAAP net (loss) income and clearly identifying the difference between the two measures. Consequently, Adjusted EBITDA should not be considered in isolation or as a substitute for net (loss) income presented in accordance with GAAP. Adjusted EBITDA as defined by us may not be comparable with similarly named measures provided by other entities.
A reconciliation of GAAP net (loss) income to Non-GAAP Adjusted EBITDA follows:
|
|
(Unaudited) |
||||||||||
|
Three Months Ended |
|
|
Nine Months Ended |
||||||||
|
|
|
|
|
||||||||
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
||
Net (loss) income |
$ |
(952,233) |
$ |
32,412 |
$ |
(2,750,084) |
$ |
(701,259) |
||||
Reconciling items: |
|
|
|
|
|
|
|
|
||||
Gain on forgiveness of unsecured promissory note |
|
- |
|
- |
|
(10,000) |
|
- |
||||
Interest and other income (expense), net |
|
412 |
|
(6,993) |
|
(5,340) |
|
(18,186) |
||||
Depreciation and amortization |
|
42,237 |
|
46,387 |
|
126,226 |
|
127,143 |
||||
Stock-based compensation expense |
|
638,589 |
|
97,157 |
|
2,270,205 |
|
286,909 |
||||
Adjusted EBITDA |
$ |
(270,995) |
$ |
168,963 |
$ |
(368,993) |
$ |
(305,393) |
||||
About Intellicheck Nasdaq: IDN
Safe Harbor Statement
Statements in this news release about Intellicheck’s future expectations, including: the advantages of our products, future demand for Intellicheck’s existing and future products, whether revenue and other financial metrics will improve in future periods, whether
View source version on businesswire.com: https://www.businesswire.com/news/home/20211110005459/en/
Investor Relations:
Media and Public Relations:
Source:
FAQ
What are Intellicheck's Q3 2021 earnings results?
How much did SaaS revenue grow in Q3 2021 for IDN?
What is Intellicheck's cash position as of September 30, 2021?
What caused the decline in gross profit margin for IDN?